These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 11377192

  • 1. Synthesis and structure-affinity relationships of 4-(5-Aryl-1,2,3,6-tetrahydropyridino)pyrimidine derivatives as corticotropin-releasing factor(1) receptor antagonists.
    Kumagai T, Okubo T, Kataoka-Okubo H, Chaki S, Okuyama S, Nakazato A.
    Bioorg Med Chem; 2001 May; 9(5):1349-55. PubMed ID: 11377192
    [Abstract] [Full Text] [Related]

  • 2. Chemical modification of aryl-1,2,3,6-tetrahydropyridinopyrimidine derivative to discover corticotropin-releasing factor(1) receptor antagonists: aryl-1,2,3,6-tetrahydropyridino-purine, -3H-1,2,3-triazolo[4,5-d)pyrimidine, -purin-8-one, and -7H-pyrrolo[2,3-d]pyrimidine derivatives.
    Kumagai T, Okubo T, Kataoka-Okubo H, Chaki S, Okuyama S, Nakazato A.
    Bioorg Med Chem; 2001 May; 9(5):1357-63. PubMed ID: 11377193
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and structure-affinity relationships of 4-methylidenepiperidine and 4-aryl-1,2,3,6-tetrahydropyridine derivatives as corticotropin-releasing factor1 receptor antagonists.
    Nakazato A, Kumagai T, Okubo T, Tanaka H, Chaki S, Okuyama S, Tomisawa K.
    Bioorg Med Chem; 2000 May; 8(5):1183-93. PubMed ID: 10882028
    [Abstract] [Full Text] [Related]

  • 4. 3-Aryl pyrazolo[4,3-d]pyrimidine derivatives: Nonpeptide CRF-1 antagonists.
    Yuan J, Gulianello M, De Lombaert S, Brodbeck R, Kieltyka A, Hodgetts KJ.
    Bioorg Med Chem Lett; 2002 Aug 19; 12(16):2133-6. PubMed ID: 12127521
    [Abstract] [Full Text] [Related]

  • 5. Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists.
    Chen C, Wilcoxen KM, Huang CQ, Xie YF, McCarthy JR, Webb TR, Zhu YF, Saunders J, Liu XJ, Chen TK, Bozigian H, Grigoriadis DE.
    J Med Chem; 2004 Sep 09; 47(19):4787-98. PubMed ID: 15341493
    [Abstract] [Full Text] [Related]

  • 6. Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonists.
    Wustrow DJ, Capiris T, Rubin R, Knobelsdorf JA, Akunne H, Davis MD, MacKenzie R, Pugsley TA, Zoski KT, Heffner TG, Wise LD.
    Bioorg Med Chem Lett; 1998 Aug 18; 8(16):2067-70. PubMed ID: 9873487
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of substituted pyrimidines as corticotropin releasing factor (CRF) receptor ligands.
    Kuppast B, Spyridaki K, Liapakis G, Fahmy H.
    Eur J Med Chem; 2014 May 06; 78():1-9. PubMed ID: 24675175
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, and biological evaluation of 1,2,3,7-tetrahydro-6h-purin-6-one and 3,7-dihydro-1h-purine-2,6-dione derivatives as corticotropin-releasing factor(1) receptor antagonists.
    Hartz RA, Nanda KK, Ingalls CL, Ahuja VT, Molski TF, Zhang G, Wong H, Peng Y, Kelley M, Lodge NJ, Zaczek R, Gilligan PJ, Trainor GL.
    J Med Chem; 2004 Sep 09; 47(19):4741-54. PubMed ID: 15341489
    [Abstract] [Full Text] [Related]

  • 9. 2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists.
    Hodgetts KJ, Yoon T, Huang J, Gulianello M, Kieltyka A, Primus R, Brodbeck R, De Lombaert S, Doller D.
    Bioorg Med Chem Lett; 2003 Aug 04; 13(15):2497-500. PubMed ID: 12852951
    [Abstract] [Full Text] [Related]

  • 10. 2-Arylpyrimidines: novel CRF-1 receptor antagonists.
    Yoon T, De Lombaert S, Brodbeck R, Gulianello M, Krause JE, Hutchison A, Horvath RF, Ge P, Kehne J, Hoffman D, Chandrasekhar J, Doller D, Hodgetts KJ.
    Bioorg Med Chem Lett; 2008 Aug 15; 18(16):4486-90. PubMed ID: 18672365
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor(1) (CRF(1)) receptor antagonists.
    Huang CQ, Grigoriadis DE, Liu Z, McCarthy JR, Ramphal J, Webb T, Whitten JP, Xie MY, Chen C.
    Bioorg Med Chem Lett; 2004 May 03; 14(9):2083-6. PubMed ID: 15080983
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pyrazolo[1,5-a]pyrimidines, triazolo[1,5-a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF₁) receptor antagonists.
    Saito T, Obitsu T, Minamoto C, Sugiura T, Matsumura N, Ueno S, Kishi A, Katsumata S, Nakai H, Toda M.
    Bioorg Med Chem; 2011 Oct 15; 19(20):5955-66. PubMed ID: 21930387
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Corticotropin-releasing hormone receptor antagonists: framework design and synthesis guided by ligand conformational studies.
    Hodge CN, Aldrich PE, Wasserman ZR, Fernandez CH, Nemeth GA, Arvanitis A, Cheeseman RS, Chorvat RJ, Ciganek E, Christos TE, Gilligan PJ, Krenitsky P, Scholfield E, Strucely P.
    J Med Chem; 1999 Mar 11; 42(5):819-32. PubMed ID: 10072680
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of benzoylpyrimidines as antagonists of the corticotropin-releasing factor-1 receptor.
    Webb TR, Moran T, Huang CQ, McCarthy JR, Grigoriadis DE, Chen C.
    Bioorg Med Chem Lett; 2004 Aug 02; 14(15):3869-73. PubMed ID: 15225687
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity relationships of 8-substituted-2-aryl-5-alkylaminoquinolines: Potent, orally active corticotropin-releasing factor-1 receptor antagonists.
    Takeda K, Terauchi T, Hashizume M, Shikata K, Taguchi R, Murata-Tai K, Fujisawa M, Takahashi Y, Shin K, Ino M, Shibata H, Yonaga M.
    Bioorg Med Chem; 2012 Nov 15; 20(22):6559-78. PubMed ID: 23062820
    [Abstract] [Full Text] [Related]

  • 18. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR, Sullivan SK, Schwarz DA, Ling N, Vale WW, Crowe PD, Grigoriadis DE.
    Biochemistry; 2004 Apr 06; 43(13):3996-4011. PubMed ID: 15049707
    [Abstract] [Full Text] [Related]

  • 19. Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists.
    Gross RS, Guo Z, Dyck B, Coon T, Huang CQ, Lowe RF, Marinkovic D, Moorjani M, Nelson J, Zamani-Kord S, Grigoriadis DE, Hoare SR, Crowe PD, Bu JH, Haddach M, McCarthy J, Saunders J, Sullivan R, Chen T, Williams JP.
    J Med Chem; 2005 Sep 08; 48(18):5780-93. PubMed ID: 16134945
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.